DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT?

DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT?

Pokaż inne wersje (1)

Large preterm infants are generally not considered good candidates for surfactant treatment until they have been intubated for progressing respiratory distress. This study has been done to detect the effect of electively providing early single-dose surfactant to large preterm babies with mild to mod...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	N Khosravi, p Mohagheghi
Format:	Artykuł
Język:	English
Wydane:	Tehran University of Medical Sciences 2008-10-01
Seria:	Acta Medica Iranica
Hasła przedmiotowe:	Preterm infants surfactant respiratory distress syndrome
Dostęp online:	https://acta.tums.ac.ir/index.php/acta/article/view/3505

Podobne zapisy

DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT?
od: N Khosravi, i wsp.
Wydane: (2008-11-01)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
od: Mandy Brasher, i wsp.
Wydane: (2021-06-01)

Clinical predictors for surfactant retreatment in preterm infants with respiratory distress syndrome: the results of a pooled analysis
od: Carlo Dani, i wsp.
Wydane: (2025-01-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
od: İ.A. Mirzayeva, i wsp.
Wydane: (2024-04-01)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
od: Ga Won Jeon
Wydane: (2019-05-01)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
od: Majid Mohammadizadeh, i wsp.
Wydane: (2015-01-01)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
od: Morteza Habibi, i wsp.
Wydane: (2024-01-01)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
od: Mohammad Kazem Sabzehei, i wsp.
Wydane: (2022-04-01)

A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome—a randomized controlled trial
od: Lorenz Auer-Hackenberg, i wsp.
Wydane: (2022-11-01)

Usage of Surfactant and Evaluation of Lung Problems in Late Preterm Infants
od: Ozlem Yilman, i wsp.
Wydane: (2023-12-01)

Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study)
od: Iuri Corsini, i wsp.
Wydane: (2023-11-01)

Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial
od: Jiajun Zhu, i wsp.
Wydane: (2020-06-01)

Surfactant Utilization Evaluation in a Major Teaching Hospital in West of Iran: An Observational, Prospective Study
od: Sajad Khiali, i wsp.
Wydane: (2021-12-01)

Expression of SP-C and Ki67 in lungs of preterm infants dying from respiratory distress syndrome
od: H. Lu, i wsp.
Wydane: (2012-07-01)

Is Less Invasive Surfactant Administration Better than INtubation-SURfactant-Extubation for Prophylactic Surfactant Replacement Therapy?
od: Hyung-Joon Joo, i wsp.
Wydane: (2022-02-01)

Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
od: Fatma Hilal Yılmaz, i wsp.
Wydane: (2021-06-01)

Prospective, non-blinded, randomized controlled trial on early administration of pulmonary surfactant guided by lung ultrasound scores in very preterm infants: study protocol
od: Jinghui Zhang, i wsp.
Wydane: (2024-07-01)

Diagnosis and management of neonatal respiratory distress syndrome in Japan: A national survey
od: Yusuke Hoshino, i wsp.
Wydane: (2023-01-01)

Surfactant therapy in late preterm infants
od: Murat Yurdakök
Wydane: (2013-08-01)

Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome
od: Mohamed Garib, i wsp.
Wydane: (2015-03-01)

Genetic Polymorphisms of LPCAT1, CHPT1 and PCYT1B and Risk of Neonatal Respiratory Distress Syndrome among a Chinese Han Population
od: Wei Shen, i wsp.
Wydane: (2020-06-01)

FiO2 Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
od: Piotr Kruczek, i wsp.
Wydane: (2021-10-01)

Evaluation of the Effect of L-Carnitine Supplementation in Preterm Neonates Suffering from Respiratory Distress Syndrome
od: Safaa Beshir, i wsp.
Wydane: (2022-06-01)

Surfactant therapy for acute respiratory distress in infants
od: Corrado Moretti, i wsp.
Wydane: (2014-10-01)

Failure of early non-invasive ventilation in preterm infants with respiratory distress syndrome in current care practice in Spanish level-III neonatal intensive care units – a prospective observational study
od: Hector Boix, i wsp.
Wydane: (2023-02-01)

Respiratory Management of the Preterm Infant: Supporting Evidence-Based Practice at the Bedside
od: Milena Tana, i wsp.
Wydane: (2023-03-01)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
od: Mehmet Yalaz, i wsp.
Wydane: (2022-03-01)

Antenatal dexamethasone use and respiratory distress in late preterm infants: results from first Vietnamese matched cohort study
od: Tran Tuan Hung Ho, i wsp.
Wydane: (2021-08-01)

Predictors of CPAP failure after less-invasive surfactant administration in preterm infants
od: Miguel Alsina-Casanova, i wsp.
Wydane: (2024-08-01)

Predictors of Nasal Continuous Positive Airway Pressure Failure in Preterm Infants With Respiratory Distress Syndrome
od: Rozhin Hesami, i wsp.
Wydane: (2024-10-01)

Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
od: Minji Heo, i wsp.
Wydane: (2020-08-01)

Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial
od: Yong Yang, i wsp.
Wydane: (2022-01-01)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
od: Silvia Mikolajcikova, i wsp.
Wydane: (2022-05-01)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
od: Ji Won Koh, i wsp.
Wydane: (2018-10-01)

Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China
od: Chun-cai Xu, i wsp.
Wydane: (2022-12-01)

Risk factors of preterm infants with CPAP intubated for mechanical ventilation
od: O. Borysiuk, i wsp.
Wydane: (2023-06-01)

The gestational effect of antenatal corticosteroids on respiratory distress syndrome in very low birth weight infants: A population-based study
od: Szu-Yu Liu, i wsp.
Wydane: (2020-08-01)

Association between Thyroid Function and Respiratory Distress Syndrome in Preterm Infants
od: Yonghyuk Kim, i wsp.
Wydane: (2022-11-01)

A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
od: Wolfgang Göpel, i wsp.
Wydane: (2023-09-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
od: Hassan Boskabadi, i wsp.
Wydane: (2024-10-01)